Financials in GBp. Standardized financial statements.
A compact view of how OptiBiotix Health Plc turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | £1.17M | £870,000 | £644,000 | £457,000 | £2.21M | £1.52M | £744,883 | £514,289 | £191,073 | £288,119 |
| Revenue Growth? | +34.0% | +35.1% | +40.9% | -79.3% | +45.3% | +104.5% | +44.8% | +169.2% | -33.7% | 0.0% |
| Cost of Revenue? | £552,000 | £539,000 | £324,000 | £213,000 | £1.09M | £643,428 | £570,064 | £162,782 | £73,706 | £139,641 |
| Gross Profit? | £614,000 | £331,000 | £320,000 | £244,000 | £1.12M | £879,819 | £174,819 | £351,507 | £117,367 | £249,905 |
| Gross Margin? | +52.7% | +38.0% | +49.7% | +53.4% | +50.7% | +57.8% | +23.5% | +68.3% | +61.4% | +86.7% |
| Operating Expenses? | £3.75M | £2.60M | £2.02M | £2.73M | £2.49M | £1.99M | £2.34M | £1.85M | £1.58M | £1.66M |
| Operating Income? | -£3.13M | -£2.27M | -£1.70M | -£2.49M | -£1.36M | -£1.11M | -£2.17M | -£1.50M | -£2.13M | -£1.52M |
| EBITDA? | -£3.13M | -£2.06M | -£1.84M | £2.75M | £6.51M | £6.31M | -£1.68M | -£1.80M | £2.10M | -£1.40M |
| Income Before Tax | -£3.94M | -£1.87M | -£2.04M | £2.44M | £6.18M | £5.71M | -£1.95M | -£1.95M | £1.69M | -£1.52M |
| Income Tax Expense | -£53,000 | -£61,000 | -£4,000 | -£146,000 | -£84,000 | -£91,635 | -£123,000 | -£54,371 | -£228,000 | -£175,000 |
| Net Income? | -£3.89M | -£1.80M | -£2.04M | £2.59M | £6.26M | £5.80M | -£2.37M | -£1.92M | £1.91M | -£1.30M |
| EPS? | £-0.04 | £-0.02 | £-0.02 | £0.03 | £0.07 | £0.07 | £-0.03 | £-0.02 | £0.02 | £-0.02 |
| Diluted EPS? | £-0.04 | £-0.02 | £-0.02 | £0.03 | £0.07 | £0.06 | £-0.03 | £-0.02 | £0.02 | £-0.02 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality